21 min. Read

Approximating Omada Health’s S-1 Before Its 2025 IPO

In this article:

This 5,500-word report includes estimates for Omada Health’s annual revenues (2015-2024), reveals some of its pricing, tracks its customer growth, details its annual net new participants, and examines how GLP-1s have likely driven significant growth for the company in 2024. Plus: Other considerations as an IPO likely nears in 2025.

The very first long-form report that Exits & Outcomes published was called Approximating Livongo Health's S-1. That was in May 2019. Almost a year later I wrote a similar report about Livongo's biggest rival at the time -- Omada Health. I fully

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!